Cited by 374T-cell and B-cell ImmunologyImmune Cell Function and InteractionDevelopmental Biology and Gene Regulation

Reprogramming of T Cells to Natural Killer–Like Cells upon Bcl11b Deletion

Open access
Li, Peng, Burke, Shannon, Wang, Juexuan, Chen, Xiongfeng, Ortiz, Mariaestela, Lee, Song-Choon, Lu, Dong, Campos, Lia +9 more·2010·Science

Abstract

One Two T: T cells develop in the thymus, where they proceed through several developmental stages, losing alternative lineage potential as they progress. The molecular regulation of this developmental process, however, is not fully understood (see the Perspective by Di Santo ). P. Li et al. (p. 85 , published online 10 June), L. Li et al. (p. 89 ), and Ikawa et al. (p. 93 ) now identify expression of the zinc finger transcription factor Bcl11b as the earliest checkpoint in T cell development in mice. Genetic deletion of Bcl11b in developing T cells inhibited commitment to the T cell lineage. Under conditions that should have stimulated T lineage differentiation, Bcl11b -deficient T cell progenitors failed to up-regulate genes associated with lineage-committed T cells and maintained stem cell– and progenitor cell–associated gene expression. In both developing and committed T cells, loss of Bcl11b resulted in the generation of cells that resembled natural killer (NK) cells in both phenotype and function. These NK-like cells could be expanded easily in vitro and possessed antitumor cytotoxicity, but they did not exhibit cytotoxicity against normal cells and were not tumorigenic. Because T cells are much easier to obtain from human patients than NK cells, deletion of Bcl11b in T cells may thus provide a source of easy-to-grow NK cells for cell-based antitumor therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1188063

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Loss of master regulators, such as Pax5 in B cells, can cause plasticity and even cancer.

    “Their loss, for example, Pax5 in B cells, can cause plasticity and even cancer6,7,55,56.”

    From Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis (2025) · cites this paper as [55]

    The paper reports that deleting the transcription factor Bcl11b caused T cells to acquire NK-cell properties, supporting the general point that loss of a lineage regulator can cause plasticity. It does not report Pax5 loss in B cells or cancer caused by regulator loss. Its tumor finding is instead that the reprogrammed cells killed tumor cells and prevented metastasis (Abstract; no page given in our copy). (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [1]Ciofani M Zúñiga-Pflücker JC Annu. Rev. Cell Dev. Biol 2007 23 463 17506693
  2. [2]Rothenberg EV Moore JE Yui MA Nat. Rev. Immunol 2008 8 9 18097446 PMC3131407
  3. [3]Takada K Jameson SC Nat. Rev. Immunol 2009 9 823 19935802
  4. [4]Tydell CC J. Immunol 2007 179 421 17579063
  5. [5]Bajoghli B Cell 2009 138 186 19559469
  6. [6]Wakabayashi Y Nat. Immunol 2003 4 533 12717433
  7. [7]Albu DI J. Exp. Med 2007 204 3003 17998389 PMC2118514
  8. [9]Vosshenrich CA Nat. Immunol 2006 7 1217 17013389
  9. [10]Hameyer D Physiol. Genomics 2007 31 32 17456738
  10. [11]Schmitt TM Zúñiga-Pflücker JC Immunity 2002 17 749 12479821
  11. [12]Schmitt TM Ciofani M Petrie HT Zúñiga-Pflücker JC J. Exp. Med 2004 200 469 15314075 PMC2211933
  12. [13]Walzer T Proc. Natl. Acad. Sci. U.S.A 2007 104 3384
  13. [14]Boos MD Ramirez K Kee BL Immunol. Res 2008 40 193 18266115
  14. [15]Chambers SM Cell Stem Cell 2007 1 578 18371395 PMC2475548
  15. [16]Gascoyne DM Nat. Immunol 2009 10 1118 19749763
  16. [17]Miaw SC Choi A Yu E Kishikawa H Ho IC Immunity 2000 12 323 10755619
  17. [18]Topark-Ngarm A J. Biol. Chem 2006 281 32272 16950772 PMC2547407
  18. [19]Kawano Y Taniguchi K Toshitani A Nomoto K J. Immunol 1986 136 4729 3711664
  19. [20]Kärre K Ljunggren HG Piontek G Kiessling R Nature 1986 319 675 3951539
  20. [21]Ljunggren HG Kärre K J. Exp. Med 1985 162 1745 3877776 PMC2187973
  21. [22]Colucci F J. Immunol 1999 162 2761 10072522
  22. [23]Gorelik E Wiltrout RH Okumura K Habu S Herberman RB Int. J. Cancer 1982 30 107 7118294
  23. [24]Lakshmikanth T J. Clin. Invest 2009 119 1251 19349689 PMC2673866
  24. [25]Rothenberg EV Nat. Immunol 2007 8 441 17440447
  25. [26]Krejcí A Bernard F Housden BE Collins S Bray SJ Sci. Signal 2009 2 ra1 19176515
  26. [27]Tun T Nucleic Acids Res 1994 22 965 8152928 PMC307916

Cited by

Sorted by citations

Authors
Li, P., Burke, S., Wang, J., Chen, X., Ortiz, M., Lee, S.-C., Lu, D., Campos, L., Goulding, D., Ng, B. L., Dougan, G., Huntly, B., Gottgens, B., Jenkins, N. A., Copeland, N. G., Colucci, F., & Liu, P.
Affiliations
  • Wellcome Sanger Institute (GB)
  • Babraham Institute (GB)
  • National Cancer Institute (US)
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
  • Wellcome Trust (GB)
  • Cambridge Institute for Medical Research, Wellcome Trust–MRC Building, Hills Road, Cambridge CB2 0XY, UK.
  • Institute of Molecular and Cell Biology (SG)
Corresponding author
Liu, Pentao
Venue
Science
Published
2010-07-02
Volume
329
Issue
5987
Pages
85-89
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2010957709
Cited by
374
References
26
Citations by year
2026: 16 · 2025: 22 · 2024: 28 · 2023: 11 · 2022: 17 · 2021: 28 · 2020: 16 · 2019: 26 · 2018: 24 · 2017: 14 · 2016: 27 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 26
FWCI
14.30
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Funders
  • Wellcome Trust (077186, 076962)
  • National Centre for the Replacement, Refinement and Reduction of Animals in Research (G0900729/1)
  • Biotechnology and Biological Sciences Research Council
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
BCL11B, T cell development, NK-like cells, lineage commitment, thymus development, zinc finger transcription factor, T cell progenitors, tumor cytotoxicity, NK cell expansion
MeSH terms
Animals, Cells, Cultured, Cytotoxicity, Immunologic, Killer Cells, Natural, Melanoma, Experimental, Mice, Inbred C57BL, Repressor Proteins, T-Lymphocytes, Tamoxifen, Signal Transduction, Receptors, Antigen, T-Cell, alpha-beta, Stromal Cells, Gene Deletion, Mice, Knockout, Gene Expression Regulation, Developmental, Coculture Techniques, Cell Lineage, Genes, T-Cell Receptor beta, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Tumor Suppressor Proteins, Lymphopoiesis, Cell Line, Tumor, Mice, Precursor Cells, T-Lymphoid, Gene Knock-In Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review